欧美午夜精品久久久久免费视-亚洲国产精品无码久久久-鲁鲁狠狠狠7777一区二区-特黄aaaaaaa片免费视频

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Mercaptopurine is an antineoplastic and immunosuppressive drug that inhibits purine nucleotide synthesis and metabolism. It is a cytotoxic agent used in the treatment of various cancers and autoimmune diseases.

50-44-2

Post Buying Request

50-44-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50-44-2 Usage

Uses

Used in Oncology:
6-Mercaptopurine is used as an antineoplastic agent for its cytotoxic effect on cancer cells. It is particularly effective in the treatment of acute lymphoblastic leukemia and other malignancies.
Used in Autoimmune Diseases:
6-Mercaptopurine is used as an immunosuppressant in the management of autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, and lupus nephritis. It helps to reduce inflammation and suppress the immune system, providing relief from symptoms and preventing disease progression.
Used in Transplant Medicine:
6-Mercaptopurine is used as an immunosuppressant in organ transplantation to prevent organ rejection and promote graft survival. It helps to suppress the recipient's immune system, allowing the transplanted organ to function without being attacked by the body's defenses.

Originator

Purinethol,Sandoz,France,1950

Manufacturing Process

7.5 g of 4-amino-6-chloro-5-nitropyrimidine was suspended in 200 ml of 1 N potassium hydrosulfide and heated on the steam bath for 2 hours while passing hydrogen sulfide through the reaction mixture. The reaction mixture was allowed to cool slowly, acidified with 10 N sulfuric acid and chilled. The precipitate consisted of 4,5-diamino-6-mercaptopyrimidine and sulfur. It was boiled with 300 ml of water, filtered hot and then chilled. The product precipitated as pale yellow needles (4.2 g); an additional 0.95 g was obtained by concentration of the mother liquors to 100 ml. A mixture of 2 g of 4,5-diamino-6-mercaptopyrimidine and 10 ml of 98% formic acid was heated at 70°C for two hours and then evaporated to dryness on the steam bath to give as a residue, 7-amino-thiazolo (5,4-d) pyrimidine. To 820 mg of 7-amino-thiazolo[5,4-d]pyrimidine was added 2.5 cc of 2 N sodium hydroxide. The water was removed under reduced pressure. The sodium salt was then heated at 240°C for one hour, during which time it melted, gave off water and resolidified. The sodium salt of 6-mercaptopurine was dissolved in 15 ml of water and acidified to pH 5 with acetic acid. Yellow crystals of 6-mercaptopurine hydrate precipitated, according to US Patent 2,933,498.

Therapeutic Function

Cancer chemotherapy

Hazard

Questionable carcinogen.

Safety Profile

Poison by ingestion, intraperitoneal, subcutaneous, parenteral, and intravenous routes. Human systemic effects by ingestion: dermatitis. Experimental teratogenic and reproductive effects. Questionable human carcinogen producing Hodgkin's disease and leukemia. Human mutation data reported. When heated to decomposition it emits very toxic fumes of SOx and NOx. See also MERCAPTANS.

Veterinary Drugs and Treatments

Veterinary uses of mercaptopurine include adjunctive therapy of lymphosarcoma, acute leukemias, and severe rheumatoid arthritis. It may have potential benefit in treating other autoimmune conditions (e.g., unresponsive ulcerative colitis) as well.

Check Digit Verification of cas no

The CAS Registry Mumber 50-44-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 50-44:
(4*5)+(3*0)+(2*4)+(1*4)=32
32 % 10 = 2
So 50-44-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N4/c1-4-5(8-2-6-1)9-3-7-4/h2-3H,1H2,(H,6,8)(H,7,9)

50-44-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name mercaptopurine

1.2 Other means of identification

Product number -
Other names 6-Mercaptopurine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50-44-2 SDS

50-44-2Synthetic route

2,6,8-trichloro-7H-purine
2562-52-9

2,6,8-trichloro-7H-purine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With potassium hydrosulfide und Erwaermen des Reaktionsprodukts mit einem Gemisch von Jod, konz.HI und rotem Phosphor;
[1,3]thiazolo[5,4-d]pyrimidin-7-amine
2846-90-4

[1,3]thiazolo[5,4-d]pyrimidin-7-amine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
at 190℃;
at 190℃;
6-amino-5-formylamino-3H-pyrimidin-4-one
64194-58-7

6-amino-5-formylamino-3H-pyrimidin-4-one

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With pyridine; tetraphosphorus decasulfide
With tetraphosphorus decasulfide; tetralin
N-(4-amino-6-thioxo-1,6-dihydro-pyrimidin-5-yl)-formamide
500542-05-2

N-(4-amino-6-thioxo-1,6-dihydro-pyrimidin-5-yl)-formamide

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With formamide at 200℃;
5-Aminoimidazole-4-thioamide
20271-18-5

5-Aminoimidazole-4-thioamide

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
at 200℃;
6-chloro-7H-purine
87-42-3

6-chloro-7H-purine

thiourea
17356-08-0

thiourea

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With ethanol
1,7-dihydro-6H-purin-6-one
68-94-0

1,7-dihydro-6H-purin-6-one

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With tetraphosphorus decasulfide; tetralin
With pyridine; tetraphosphorus decasulfide
Multi-step reaction with 2 steps
1: N,N-dimethyl-aniline; POCl3
2: ethanol
View Scheme
S6-(N-methyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
126616-94-2

S6-(N-methyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; Mechanism; pH 7.1;
S6-(N-methyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine
126646-36-4

S6-(N-methyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; pH 7.1;
S6-(N-ethyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
126616-96-4

S6-(N-ethyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; pH 7.1;
S6-(N-ethyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine
126585-34-0

S6-(N-ethyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; pH 7.1;
S6-(N-butyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
126585-38-4

S6-(N-butyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; pH 7.1;
S6-(N-methyl-N-butoxycarbonyl)aminomethyl-6-mercaptopurine
126585-33-9

S6-(N-methyl-N-butoxycarbonyl)aminomethyl-6-mercaptopurine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
With phosphate buffer; water at 32℃; Rate constant; pH 7.1;
acetic anhydride
108-24-7

acetic anhydride

7-(dimethylamino)methyl-6-mercaptopurine
119056-59-6

7-(dimethylamino)methyl-6-mercaptopurine

A

6H-purine-6-thione
50-44-2

6H-purine-6-thione

B

7-acetyloxymethyl-6-mercaptopurine
119346-80-4

7-acetyloxymethyl-6-mercaptopurine

C

9-acetyloxymethyl-6-mercaptopurine
114208-88-7

9-acetyloxymethyl-6-mercaptopurine

D

S6,3-bisacetyloxymethyl-6-mercaptopurine
111621-56-8

S6,3-bisacetyloxymethyl-6-mercaptopurine

Conditions
ConditionsYield
With sodium acetate In dimethylsulfoxide-d6 for 20h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
6-thiocyanato-7(9)H-purine
19447-73-5

6-thiocyanato-7(9)H-purine

tetrachloromethane
56-23-5

tetrachloromethane

water
7732-18-5

water

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
at 25℃; Kinetics;
sodium-salt of 6-amino-5-formylamino-3H-pyrimidine-4-thione

sodium-salt of 6-amino-5-formylamino-3H-pyrimidine-4-thione

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
at 240℃;
8-chloroxanthine
13548-68-0

8-chloroxanthine

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-aniline; POCl3
2: aqueous KHS / und Erwaermen des Reaktionsprodukts mit einem Gemisch von Jod, konz.HI und rotem Phosphor
View Scheme
N-(4-amino-6-benzylsulfanyl-pyrimidin-5-yl)-formamide
91560-22-4

N-(4-amino-6-benzylsulfanyl-pyrimidin-5-yl)-formamide

6H-purine-6-thione
50-44-2

6H-purine-6-thione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium; liquid NH3
2: formamide / 200 °C
View Scheme
Ru(2,2'-biquinoline)dichlorid

Ru(2,2'-biquinoline)dichlorid

6H-purine-6-thione
50-44-2

6H-purine-6-thione

[Ru(2,2-biquinoline)2(6-mercaptopurine)]Cl

[Ru(2,2-biquinoline)2(6-mercaptopurine)]Cl

Conditions
ConditionsYield
With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness;89%
1-bromo-4-butene
5162-44-7

1-bromo-4-butene

6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-(but-3-enyl)sulfanylpurine

6-(but-3-enyl)sulfanylpurine

Conditions
ConditionsYield
With potassium hydroxide In water; N,N-dimethyl-formamide for 2h;87%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

ammonium hexafluorophosphate

ammonium hexafluorophosphate

C24H24Cl2N4Ru

C24H24Cl2N4Ru

[Ru(6,6-dimethylbipyridine)2(6-mercaptopurine)]hexafluorophosphate

[Ru(6,6-dimethylbipyridine)2(6-mercaptopurine)]hexafluorophosphate

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione; C24H24Cl2N4Ru With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness;
Stage #2: ammonium hexafluorophosphate In ethanol; water Inert atmosphere; Schlenk technique; Darkness;
83%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

N-(4-Nitrobenzoyl)-1-pyrrolidinecarbimidoyl Chloride
76098-31-2

N-(4-Nitrobenzoyl)-1-pyrrolidinecarbimidoyl Chloride

N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(pyrrolidin-1-yl)methyliden>-4-nitrobenzamid

N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(pyrrolidin-1-yl)methyliden>-4-nitrobenzamid

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 80℃; for 1.5h;72%
Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere;
Stage #2: D-glucose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux;
68%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

D-galactose pentaacetate
25878-60-8

D-galactose pentaacetate

6-mercapto-9-(2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)purine

6-mercapto-9-(2',3',4',6'-tetra-O-acetyl-β-D-galactopyranosyl)purine

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere;
Stage #2: D-galactose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux;
63%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

4-Chloro-N-[1-chloro-1-piperidin-1-yl-meth-(Z)-ylidene]-benzamide

4-Chloro-N-[1-chloro-1-piperidin-1-yl-meth-(Z)-ylidene]-benzamide

4-chloro-N-<(6,7-dihydro-6-thioxo-1H-purin-7yl)(piperidin-1-yl)methyliden>benzamid

4-chloro-N-<(6,7-dihydro-6-thioxo-1H-purin-7yl)(piperidin-1-yl)methyliden>benzamid

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide 1.) 80 deg C, 5 h, 2.) RT, 2 d;62%
4-Chloro-N-[1-chloro-1-morpholin-4-yl-meth-(Z)-ylidene]-benzamide

4-Chloro-N-[1-chloro-1-morpholin-4-yl-meth-(Z)-ylidene]-benzamide

6H-purine-6-thione
50-44-2

6H-purine-6-thione

4-chloro-N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(morpholin-1-yl)methyliden>benzamid

4-chloro-N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(morpholin-1-yl)methyliden>benzamid

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide 1.) 80 deg C, 5 h, 2.) RT, 2 d;60%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

cis-Ru(II)(bipyridine)2Cl2*0.5H2O

cis-Ru(II)(bipyridine)2Cl2*0.5H2O

sodium perchlorate

sodium perchlorate

[Ru(2.2'-bipyridine)2(7H-purine-6(1H)thione)][ClO4]2*2.5H2O

[Ru(2.2'-bipyridine)2(7H-purine-6(1H)thione)][ClO4]2*2.5H2O

Conditions
ConditionsYield
With NaOH In methanol; water org. ligand suspended in aq. MeOH; pH adjusted to 8-9 (aq. NaOH); Ru complex added; mixt. refluxed for 3 h at 90°C; cooled to room temp.;NaClO4 added; mixt. concd. by rotary evaporator; recrystd. (H2O/MeOH); elem. anal.;60%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

1,2,3,4-tetra-O-acetyl-D-xylopyranose
62446-93-9

1,2,3,4-tetra-O-acetyl-D-xylopyranose

6-mercapto-9-(2',3',4'-tri-O-acetyl-β-D-xylopyranosyl)purine

6-mercapto-9-(2',3',4'-tri-O-acetyl-β-D-xylopyranosyl)purine

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere;
Stage #2: 1,2,3,4-tetra-O-acetyl-D-xylopyranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux;
60%
1,2,3,4-Tetra-O-acetyl-D-lyxopyranose
151908-65-5

1,2,3,4-Tetra-O-acetyl-D-lyxopyranose

6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-mercapto-9-(2',3',4'-tri-O-acetyl-β-D-lyxopyranosyl)purine

6-mercapto-9-(2',3',4'-tri-O-acetyl-β-D-lyxopyranosyl)purine

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere;
Stage #2: 1,2,3,4-Tetra-O-acetyl-D-lyxopyranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux;
58%
Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere;
Stage #2: D-Mannose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux;
55%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

prenyl bromide
870-63-3

prenyl bromide

6-prenylsulfanylpurine

6-prenylsulfanylpurine

Conditions
ConditionsYield
With potassium hydroxide In ethanol; water for 2h;53%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

A

S6,9-bispivaloyloxymethyl-6-mercaptopurine
80693-25-0

S6,9-bispivaloyloxymethyl-6-mercaptopurine

B

S6,3-bispivaloyloxymethyl-6-mercaptopurine

S6,3-bispivaloyloxymethyl-6-mercaptopurine

C

2,2-Dimethyl-propionic acid 6-(2,2-dimethyl-propionyloxymethylsulfanyl)-purin-7-ylmethyl ester

2,2-Dimethyl-propionic acid 6-(2,2-dimethyl-propionyloxymethylsulfanyl)-purin-7-ylmethyl ester

D

2,2-Dimethyl-propionic acid 1-(2,2-dimethyl-propionyloxymethyl)-6-thioxo-1,6-dihydro-purin-9-ylmethyl ester

2,2-Dimethyl-propionic acid 1-(2,2-dimethyl-propionyloxymethyl)-6-thioxo-1,6-dihydro-purin-9-ylmethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane Ambient temperature;A 45%
B 8%
C 0.3%
D 1%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

bis(6-purinyl) disulfide
49808-20-0

bis(6-purinyl) disulfide

Conditions
ConditionsYield
With iodine; potassium iodide In phosphate buffer at 40℃; pH=7.5;41%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-Bromo-2-(1-bromoethyl)-3-phenyl-4H-chromen-4-one
1300581-25-2

6-Bromo-2-(1-bromoethyl)-3-phenyl-4H-chromen-4-one

2-(1-(9H-Purin-6-ylthio)ethyl)-6-bromo-3-phenyl-4H-chromen-4-one
1300583-11-2

2-(1-(9H-Purin-6-ylthio)ethyl)-6-bromo-3-phenyl-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 6-Bromo-2-(1-bromoethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h;
37%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

fac-[CoCl3(1,4,7-triazacyclononane)]
58723-65-2

fac-[CoCl3(1,4,7-triazacyclononane)]

A

Co3(C5H2N4S)3(C6H15N3)3(3+)*3Cl(1-)*11H2O=[Co3(C5H2N4S)3(C6H15N3)3]Cl3*11H2O

Co3(C5H2N4S)3(C6H15N3)3(3+)*3Cl(1-)*11H2O=[Co3(C5H2N4S)3(C6H15N3)3]Cl3*11H2O

B

Co4(C5H2N4S)4(C6H15N3)4(4+)*4ClO4(1-)*6H2O=[Co4(C5H2N4S)4(C6H15N3)4](ClO4)4*6H2O

Co4(C5H2N4S)4(C6H15N3)4(4+)*4ClO4(1-)*6H2O=[Co4(C5H2N4S)4(C6H15N3)4](ClO4)4*6H2O

Conditions
ConditionsYield
With NaOH; Sephadex A-25, ClO4-form In water pH-adjustment of soln. of equimolar amts. Co-complex and purine to 8-9 (NaOH, repeated evapn. to dryness at 60°C (stirring) and dissoln. in water; concn., filtration off of trimer, chromy. (Sephadex C25, ClO4-form, hot water), crystn. (two crops); elem. anal.;A 20%
B 36%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

N-[1-Chloro-1-piperidin-1-yl-meth-(Z)-ylidene]-4-nitro-benzamide
76098-33-4

N-[1-Chloro-1-piperidin-1-yl-meth-(Z)-ylidene]-4-nitro-benzamide

A

N-<(6,9-dihydro-6-thioxo-1H-purin-9-yl)(piperidin-1-yl)methyliden>-4-nitrobenzamid

N-<(6,9-dihydro-6-thioxo-1H-purin-9-yl)(piperidin-1-yl)methyliden>-4-nitrobenzamid

B

N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(piperidin-1-yl)methyliden>-4-nitrobenzamid

N-<(6,7-dihydro-6-thioxo-1H-purin-7-yl)(piperidin-1-yl)methyliden>-4-nitrobenzamid

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 72h; Ambient temperature;A 32%
B 35%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

2-(Bromomethyl)-3-phenyl-4H-chromen-4-one
1300581-11-6

2-(Bromomethyl)-3-phenyl-4H-chromen-4-one

2-((9H-Purin-6-ylthio)methyl)-3-phenyl-4H-chromen-4-one
1300582-87-9

2-((9H-Purin-6-ylthio)methyl)-3-phenyl-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 2-(Bromomethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h;
33%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-Bromo-2-(bromomethyl)-3-phenyl-4H-chromen-4-one
1300581-10-5

6-Bromo-2-(bromomethyl)-3-phenyl-4H-chromen-4-one

2-[(9H-Purin-6-ylthio)methyl]-6-bromo-3-phenyl-4H-chromen-4-one
1300582-89-1

2-[(9H-Purin-6-ylthio)methyl]-6-bromo-3-phenyl-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: 6-Bromo-2-(bromomethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h;
28%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

ammonium hexafluorophosphate

ammonium hexafluorophosphate

C29H23ClN5Ru

C29H23ClN5Ru

[Ru(tpy)(6,9-dimethylphenanthroline)(6-mercaptopurine)]PF6

[Ru(tpy)(6,9-dimethylphenanthroline)(6-mercaptopurine)]PF6

Conditions
ConditionsYield
Stage #1: 6H-purine-6-thione; C29H23ClN5Ru In methanol; water Reflux; Inert atmosphere; Schlenk technique; Darkness;
Stage #2: ammonium hexafluorophosphate In ethanol; water Inert atmosphere; Schlenk technique; Darkness;
27%
[Ru(1,10-phenanthroline)2Cl2]

[Ru(1,10-phenanthroline)2Cl2]

6H-purine-6-thione
50-44-2

6H-purine-6-thione

[Ru(phenanthroline)2(6-mercaptopurine)]Cl

[Ru(phenanthroline)2(6-mercaptopurine)]Cl

Conditions
ConditionsYield
With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness;27%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

C42H31ClN4PRu(1+)*F6P(1-)

C42H31ClN4PRu(1+)*F6P(1-)

[Ru(phenanthroline)2(triphenylphosphine)(6-mercaptopurine)]PF6

[Ru(phenanthroline)2(triphenylphosphine)(6-mercaptopurine)]PF6

Conditions
ConditionsYield
With triethylamine In methanol; water Reflux; Darkness; Schlenk technique; Inert atmosphere;16%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

cadmium(II) bromide tetrahydrate

cadmium(II) bromide tetrahydrate

[Cd2Br4(6-mercaptopurine)2]*2H2O

[Cd2Br4(6-mercaptopurine)2]*2H2O

Conditions
ConditionsYield
With hydrogen bromide In water at 70℃; for 3h; pH=Ca. 1 - 2;3.8%
6H-purine-6-thione
50-44-2

6H-purine-6-thione

Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

S6-pivaloyloxymethyl-6-mercaptopurine

S6-pivaloyloxymethyl-6-mercaptopurine

Conditions
ConditionsYield
In dimethyl sulfoxide Ambient temperature;2.5%
2-bromomethylfuran
4437-18-7

2-bromomethylfuran

6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-furfurylmercapto-7(9)H-purine
6741-85-1

6-furfurylmercapto-7(9)H-purine

Conditions
ConditionsYield
With sodium hydroxide; diethyl ether
2-Chloromethylthiophene
765-50-4

2-Chloromethylthiophene

6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-[2]thienylmethylsulfanyl-7(9)H-purine
6975-77-5

6-[2]thienylmethylsulfanyl-7(9)H-purine

Conditions
ConditionsYield
With potassium carbonate; N,N-dimethyl-formamide
6-amino-5-bromo-2,4(1H,3H)-pyrimidinedione
6312-73-8

6-amino-5-bromo-2,4(1H,3H)-pyrimidinedione

6H-purine-6-thione
50-44-2

6H-purine-6-thione

6-amino-5-(7(9)H-purin-6-ylmercapto)-1H-pyrimidine-2,4-dione

6-amino-5-(7(9)H-purin-6-ylmercapto)-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
With ethanol

50-44-2Relevant articles and documents

A THIONATION PROCESS AND A THIONATING AGENT

-

Page/Page column 18, (2012/08/27)

A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P2S5·2 C5H5N as a thionating agent. A thionating agent which is crystalline P2S5·2 C5H5N

A thionation process and a thionating agent

-

Page/Page column 14, (2012/08/14)

A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P2S5·2 C5H5N as a thionating agent. A thionating agent which is crystalline P2S5·2 C5H5N.

Thionations using a P4S10-pyridine complex in solvents such as acetonitrile and dimethyl sulfone

Bergman, Jan,Pettersson, Birgitta,Hasimbegovic, Vedran,Svensson, Per H.

experimental part, p. 1546 - 1553 (2011/06/11)

Tetraphosphorus decasulfide (P4S10) in pyridine has been used as a thionating agent for a long period of time. The moisture-sensitive reagent has now been isolated in crystalline form, and the detailed structure has been determined by X-ray crystallography. The thionating power of this storable reagent has been studied and transferred to solvents such as acetonitrile in which it has proven to be synthetically useful and exceptionally selective. Its properties have been compared with the so-called Lawesson reagent (LR). Particularly interesting are the results from thionations at relatively high temperatures (165 °C) in dimethyl sulfone as solvent. Under these conditions, for instance, acridone and 3-acetylindole could quickly be transformed to the corresponding thionated derivatives. Glycylglycine similarly gave piperazinedithione. At these temperatures, LR is inefficient due to rapid decomposition. The thionated products are generally cleaner and more easy to obtain because in the crystalline reagent, impurities which invariably are present in the conventional reagents, P4S 10 in pyridine or LR, have been removed. 2011 American Chemical Society.

PURINE NUCLEOSIDE ANALOGS

-

Page/Page column 26-27, (2008/06/13)

The present invention is directed to purine nucleoside analogs of the general Formula (I), or tautomers thereof, physiologically acceptable salts, solvents and physiologically functional derivatives thereof, and pharmaceutical compositions comprising such compounds, salts and derivatives, which are useful as anti-bacterial and anti-protozoan agents. The invention is also directed to methods for treating a bacterial or protozoan infection in a mammal and use of the compounds for inhibiting the growth of a bacteria or protozoa.

Chemical transformations of 6-[(1-methyl-4-nitro-5-imidazolyl)-thio]purine (azathioprine)

Kochergin,Aleksandrova,Korsunskii

, p. 311 - 318 (2007/10/03)

The chemical transformations of 6-[(1-methyl-4-nitro-5-imidazolyl)thio]purine (azathiopurine)- hydrogenation, acetylation, alkylation by lower alkyl halides at positions 7 and 9 of the purine ring, hydrolytic cleavage at the C(6)-S and S-C(5) bonds - were studied.

Synthesis and some properties of 6-(ω-aroylbutylthio)purines

Gromov,Skachilova,Aleksandrova,Kochergin

, p. 1225 - 1229 (2007/10/03)

A series of 6-(ω-aroylthio)purines, which have not been described in the literature, has been obtained by the reaction of 6-purinethione with ω-chlorovalerophenone and its substituted derivatives. Some properties of the compounds synthesized have been studied, viz. reaction at the carbonyl group, methylation, and hydrolysis. 1999 KluwerAcademic/Plenum Publishers.

Alkylation of 6-mercaptopurine (6-MP) with N-alkyl-N-alkoxycarbonylaminomethyl chlorides: S6-(N-alkyl-N-alkoxycarbonyl)aminomethyl-6-MP prodrug structure effect on the dermal delivery of 6-MP

Siver,Sloan

, p. 66 - 73 (2007/10/02)

The S6-(N-alkyl-N-alkoxycarbonyl)aminomethyl-6-MP (6-CARB-6-MP) prodrugs 5-20 were synthesized from the reaction of 6-MP weith N-alkyl-N-alkyoxycarbonylaminomethyl chlorides (4) in dimethyl sulfoxide in overall yields of 5-62%, depending on the N-alkyl and the alkoxy groups involved. The derivatives were fully characterized by spectral and micranalyses. The assignment of the substitution pattern as S6-alkyl was based on comparisons of the UV, 1H NMR and 13C NMR spectra with model compounds. A S6,9-bis-alkyl derivative was obtained from the reaction of 2 equivalents of 4 with 6-MP but the product was unstable and decomposed on standing to a 9-alkyl derivative. The 6-CARB-6-MP prodrugs reverted to 6-MP in water by an S(N)1-type mechanism involving unimolecular charge separation in the transition state of the rate determining step. There was no effect of dermal enzymes on the rate of hydrolysis. The solubilities in isopropyl myristate (IPM) for all of the 6-CARB-6-MP prodrugs were significantly greater than the solubility of 6-MP in IPM but only one prodrug (5) was apparently even as soluble as 6-MP in water. Selected 6-CARB-6-MP prodrugs were examined in diffusion cell experiments. Only the N-methyl-N-methoxycarbonyl derivative 5 gave a steady-state rate of delivery of 6-MP from IPM that was significantly greater than the steady-state rate of delivery of 6-MP from 6-MP in IPM. All the other derivatives gave steady-state rates of delivery of 6-MP from IPM that were either not significantly different, or were significantly lower than the rate obtained from 6-MP in IPM. In all cases, the effect of the 6-CARB-6-MP:IPM suspensions on the permeability of the skin, as determined by the second application flux of theophylline:propylene glycol, was of the same magnitude as the effect of IPM alone.

Hydroxymethylation and aminomethylation of 6-mercaptopurine and its derivatives

Siver,Sloan,Waranis,Saab

, p. 1077 - 1081 (2007/10/02)

Labile aminomethyl and hydroxymethyl derivatives of 6-mercaptopurine (I) (6-MP) and S6-acyloxymethyl-6-MP hav been converted to stable acetyloxymethyl derivatives by their reaction with acetic anhydride. Analysis of the reaction products and comparison of their 1H nmr spectra and hplc spectra chromatograms with those of acetyloxymethyl derivatives of known structures suggested 1) that the aminomethyl derivatives of 6-MP were 7-substituted derivatives, 2) that the aminomethyl derivative of S6-acetyloxylmethyl-6-MP was a 9-derivative, 3) that the hydroxymethyl derivative of 6-MP was a mixture of 7-substituted and S6,3-disbustituted derivatives, and 4) that the hydroxymethyl derivative of S6-pivaloyloxymethyl-6-MP was a 9-substituted derivative. In addition, a previously unreported dialkyl derivative of 6-MP VI was isolated from its reaction with aminomethylating agent and characterized. Analyses of the 1H nmr spectra and hplc chromatograms of the reaction of VI with acetic anhydride suggested that VI was a 1,7-disubstituted derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50-44-2